Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phio Pharmaceuticals (PHIO) Total Liabilities (2016 - 2021)

Phio Pharmaceuticals' Total Liabilities history spans 10 years, with the latest figure at $2.7 million for Q3 2021.

  • For Q3 2021, Total Liabilities fell 3.19% year-over-year to $2.7 million; the TTM value through Sep 2021 reached $2.7 million, down 3.19%, while the annual FY2020 figure was $2.7 million, 18.81% up from the prior year.
  • Total Liabilities reached $2.7 million in Q3 2021 per PHIO's latest filing, down from $2.8 million in the prior quarter.
  • In the past five years, Total Liabilities ranged from a high of $2.8 million in Q2 2021 to a low of $1.7 million in Q4 2018.
  • Average Total Liabilities over 5 years is $2.4 million, with a median of $2.5 million recorded in 2021.
  • Peak YoY movement for Total Liabilities: skyrocketed 85.5% in 2017, then dropped 23.0% in 2018.
  • A 5-year view of Total Liabilities shows it stood at $2.3 million in 2017, then fell by 23.0% to $1.7 million in 2018, then skyrocketed by 31.36% to $2.3 million in 2019, then rose by 18.81% to $2.7 million in 2020, then decreased by 0.92% to $2.7 million in 2021.
  • Per Business Quant, the three most recent readings for PHIO's Total Liabilities are $2.7 million (Q3 2021), $2.8 million (Q2 2021), and $2.5 million (Q1 2021).